
Neuraxis rose 159.3% from $2.41 to $6.25, ahead of the S&P 500's +9.8%. Its worst day was Feb 23 (−14.1%), and its low came Nov 17 at $2.31.
Nov 11, 2025 – Nov 10, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Neuraxis closed at its lowest level of the year, 4.1% below where the year started.
−1.3% · S&P 500 −0.9%
Neuraxis shares rose 25.2%, while the S&P 500 rose 0.6%.
Story events cover the past 12 months · Times ET
+25.2%, the year's best day · S&P 500 +0.6%
Neuraxis shares fell 14.1%, while the S&P 500 fell 1.0%.
−14.1%, the year's worst day · S&P 500 −1.0%
EPS of $-0.17 beat the $-0.21 estimate on $968,127.00 revenue (est. $850,000.00).
+2.4% · S&P 500 −0.5%
Neuraxis shares rose 12.0%, while the S&P 500 rose 2.9%.
+12.0% · S&P 500 +2.9%
EPS of $-0.18 beat the $-0.19 estimate on $1.6M revenue (est. $1.4M).
+1.5% · S&P 500 −0.2%
EPS of $-0.19 beat the $-0.32 estimate on $1.9M revenue (est. $2.0M).
−7.6% · S&P 500 −0.3%
Neuraxis shares rose 21.8%, while the S&P 500 fell 0.4%.
+21.8% · S&P 500 −0.4%
Neuraxis shares rose 18.5%, while the S&P 500 rose 0.3%.
+18.5% · S&P 500 +0.3%
EPS of $-0.52 missed the $-0.21 estimate on $2.0M revenue (est. $2.1M).
+5.9% · S&P 500 +2.4%
Where it ended: a close of $6.25 on Nov 10, 2026.
Nothing in the past 12 months.
All NRXS dividend historyChart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for NRXS and SPY from Benzinga historical bars. Not investment advice.